There were 1,069 press releases posted in the last 24 hours and 219,857 in the last 365 days.

Increase in incidences of kidney diseases, issues associated with kidney transplants, and surge in prevalence of lifestyle and chronic diseases.

PORTLAND, OREGON, UNITED STATES, August 18, 2022 /EINPresswire.com/ -- Allied Market Research published a report titled, "Hemodialysis and Peritoneal Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables): Opportunity Analysis and Industry Forecast, 2020–2027." According to the report, the global hemodialysis and peritoneal dialysis industry was estimated at $15.68 billion in 2019, and is expected to hit $22.16 billion by 2027, registering a CAGR of 6.0% from 2020 to 2027.

Download Detailed COVID-19 Impact Sample Report at:

https://www.alliedmarketresearch.com/request-for-customization/3474?reqfor=covid

Increase in incidences of kidney diseases, issues associated with kidney transplants, and surge in prevalence of lifestyle and chronic diseases drive the growth of the global hemodialysis and peritoneal dialysis market. On the other hand, complications in dialysis treatment and reimbursement policy concerns in emerging nations impede the growth to some extent. However, shift in preference of patients for home hemodialysis and rise in improved market strategies by key players are anticipated to pave the way for lucrative opportunities in the coming years.

Hemodialysis and peritoneal dialysis is the most popular and preferred form of treatment for chronic renal diseases and kidney failures as compared to kidney transplantation. On the contrary, factors, such as non-eligibility of patients suffering from heart or liver disease for kidney transplantation, rise in incidences of kidney failures, growth in number of ESRD patients, increase in occurrences of diabetes, surge in funding for development of new products with advanced technology, and lack of matching donors for kidney transplantation are expected to propel growth of the hemodialysis and peritoneal dialysis market during the forecast period.

However, lack of awareness about kidney diseases, complications associated with hemodialysis and peritoneal dialysis treatments, and reduction in reimbursements for dialysis across developing nations are expected to obstruct the market growth. The peritoneal dialysis segment is predicted to grow at the highest rate and offer beneficial opportunities for market players. Peritoneal dialysis is preferred over hemodialysis, owing to advantages it offers, such as low number of clinical visits, negligible usage of needles, and easy-to-use machinery, which boosts the segment growth.

For Purchase Inquiry of Hemodialysis And Peritoneal Dialysis Market Report:

https://www.alliedmarketresearch.com/purchase-enquiry/3474

♦ The global hemodialysis and peritoneal dialysis market has not been much affected by the outbreak of covid-19, since the rules and regulations pertaining to pandemic have not been imposed on the healthcare sector.

♦ However, major surgeries such as kidney transplants were postponed during the first phase of the lockdown, thereby influencing the hemodialysis and peritoneal dialysis market to certain extent.

The consumables segment to dominate during the forecast period-

Based on product, the consumables segment accounted for 92% of the global hemodialysis and peritoneal dialysis market revenue in 2019, and is expected to lead the trail by 2027. The same segment would also exhibit the fastest CAGR of 6.1% from 2020 to 2027. This is because these products are used frequently and they constantly need to be replaced with new ones.

Asia-Pacific, followed by North America, to dominate in terms of revenue-

Based on geography, Asia-Pacific, followed by North America, held the largest share in 2019, garnering more than two-fifths of the global hemodialysis and peritoneal dialysis market. The same region would also register the fastest CAGR of 7.2% by 2027. Increase in cases of ESRD, CKDs, diabetes, and hypertension, coupled with surge in diagnosis rates in this region are estimated to drive the market growth.

Connect With Analyst In A Single Click:

https://www.alliedmarketresearch.com/connect-to-analyst/3474

Fresenius Medical Care AG & Co. KGaA Baxter International Inc. Nipro Corporation B Braun Melsungen Ag Nikkiso Co., Ltd. Becton Dickinson And Company (C. R. Bard, Inc.) Cook Group Angiodynamics Inc. Medtronic PLC Asahi Kasei Corp

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

David Correa Allied Analytics LLP 800-792-5285 email us here Visit us on social media: Facebook Twitter LinkedIn

EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.

© 1995-2022 Newsmatics Inc. dba EIN Presswire All Right Reserved.